Format

Send to

Choose Destination
Mol Ther Nucleic Acids. 2019 Jun 7;16:442-451. doi: 10.1016/j.omtn.2019.03.011. Epub 2019 Apr 11.

Drug Resistance-Related Competing Interactions of lncRNA and mRNA across 19 Cancer Types.

Author information

1
College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, China.
2
College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
3
College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, China. Electronic address: xfsong@nuaa.edu.cn.
4
Department of Pathophysiology, School of Medicine, Southeast University, Nanjing 210009, China. Electronic address: lw2247@yeah.net.
5
College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, China. Electronic address: weijiang@nuaa.edu.cn.

Abstract

Drug resistance is a common cause of treatment failure in cancer therapy, and molecular mechanisms need further exploration. Competing endogenous RNAs (ceRNAs) can influence drug response by participating in various biological processes, including regulation of cell cycle, signal transduction, and so on. In this study, we systematically explored resistance from the perspective of ceRNA modules. First, we constructed a general ceRNA network, involving 83 long non-coding RNAs (lncRNAs) and 379 mRNAs. Next, we identified the drug resistance-related modules for 138 drugs and 19 cancer types, totaling 758 drug-cancer conditions. Function analysis showed that resistance-related biological processes were enriched in these modules, such as regulation of cell proliferation, DNA damage repair, and so on. Pan-drug and pan-cancer analyses revealed some common and specific modules across multiple drugs or cancers. In addition, we also found that drug pairs with common modules have similar structure, indicating high risk for multidrug resistance (MDR). Finally, we speculated that ceRNA pair GAS5-RPL8 could regulate drug resistance because low expression of GAS5 would enhance microRNA (miRNA)-mediated inhibition of RPL8. In total, we investigated the drug resistance by using ceRNA modules and proposed that ceRNA modules may be new markers for drug resistance that indicated a possible novel mechanism.

KEYWORDS:

ceRNA; drug resistance; lncRNA; network module; pan-cancer; pan-drug

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center